Press Releases - 2023-01-05

Date	Title	Company
05-Jan-2023	Sartorius Collaborates with RoosterBio to Advance Downstream Purification Processes for the Manufacture of Exosomes	B3C newswire
05-Jan-2023	Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma	Dermapharm Holding SE
05-Jan-2023	FDA accepts nirsevimab application as first protective option against RSV disease for all infants	Sanofi
05-Jan-2023	X-Chem and Sironax Begin Neurodegenerative Disease Drug Discovery Research Partnership	X-Chem
05-Jan-2023	Nitinol Medical Devices Market exhibiting CAGR of 9% by 2032, owing to increasing number of percutaneous coronary intervention (PCI) procedures \| insightSLICE	insightSLICE
05-Jan-2023	BioVersys Extends its Series C Round to CHF 32.6 Million with Investment from the AMR Action Fund	BioVersys
05-Jan-2023	Nouscom Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate NOUS-209 in combination with KEYTRUDA® (pembrolizumab) in a Phase 2 Randomized Trials in dMMR/MSI-High Metastatic Colorectal Cancer	Nouscom
05-Jan-2023	Adcendo ApS Announces License Agreement with Duality Biologics on Next-generation ADC Platform	Adcendo ApS
05-Jan-2023	Medical Device Outsourcing Market is geared to grow at a CAGR of 11.5% from 2023 to 2032 \| insightSLICE	insightSLICE
05-Jan-2023	iOnctura provides development update on first-in-class semi-allosteric PI3Kδ inhibitor program	iOnctura
05-Jan-2023	Coagulation Analyzers Market to achieve CAGR of 7.5% by 2032, owing to increasing the prevalence of heart diseases \| insightSLICE	insightSLICE
05-Jan-2023	Cell and Tissue Preservation Market expanding growth at a CAGR of 11% from 2023 to 2032, owing to rising prevalence of injuries \| insightSLICE	insightSLICE
05-Jan-2023	Blood Clot Retrieval Devices Market exhibiting CAGR of 14% by 2032, owing to growing prevalence of stroke \| insightSLICE	insightSLICE
05-Jan-2023	Asparaginase Market is anticipated to expand at a CAGR of 16.1% By 2032 \| Exclusive Report by insightSLICE	insightSLICE
05-Jan-2023	BioVersys Extends its Series C Round to CHF 32.6 Million with Investment from the AMR Action Fund	B3C newswire
05-Jan-2023	MorphoSys Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability	MorphoSys AG
05-Jan-2023	Ad hoc: MorphoSys AG Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability	MorphoSys AG
05-Jan-2023	Orion and Amneal enter strategic partnership – Orion receives exclusive licence to commercialise Amneal’s generic products in Europe, Australia and New Zealand	Orion Corporation
05-Jan-2023	Sosei Heptares Notes its Partner Tempero Bio has Received FDA Clearance to Advance Clinical Development of TMP-301 for Treatment of Alcohol and Substance Use Disorders	Sosei Heptares
05-Jan-2023	Transgene Announces Financial Calendar for 2023	Transgene